Zobrazeno 1 - 10
of 10
pro vyhledávání: '"C M Cuttica"'
Autor:
M Bagnasco, M Cabria, M Caputo, A Montepagani, C M Cuttica, V Altrinetti, Francesca Cecoli, Massimo Giusti, E M Ceresola, U. Filippi, F Minuto, M Raffa, D Saverino, M Cappagli
Publikováno v:
European Thyroid Journal. 5:180-186
Papillary thyroid microcarcinoma (MPTC) has an excellent prognosis. We aimed to evaluate the evolution of therapeutic strategies over time and the clinical outcome of MPTC.In this retrospective multicenter observational study in a northwest Italian r
Publikováno v:
The Endocrinologist. 9:309-312
Autor:
Menichini U, Giordano G, Fattacciu G, Malagamba D, E Rasore, Meineri I, C M Cuttica, Massimo Giusti
Publikováno v:
European Journal of Clinical Investigation. 28:13-19
Background We examined the effect of growth hormone (GH) administration on the psychological capacity and sense of well-being in 25 patients with adult-onset GH-deficiency (GHD). Methods Very low dosages (0.5–1.0 UI day−1 s.c. at bed-time) of rec
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 81:2089-2097
The objective of the study was to determine the tolerability and effectiveness of the slow release (SR) somatostatin analog lanreotide in active acromegaly. Fifty-seven patients, unselected in terms of their previous responsiveness to octreotide ther
Autor:
M, Giusti, I, Meineri, D, Malagamba, C M, Cuttica, G, Fattacciu, U, Menichini, E, Rasore, G, Giordano
Publikováno v:
European journal of clinical investigation. 28(1)
We examined the effect of growth hormone (GH) administration on the psychological capacity and sense of well-being in 25 patients with adult-onset GH-deficiency (GHD).Very low dosages [0.5-1.0 UIday(-1) s.c. at bed-time] of recombinant human (rh)-GH
Publikováno v:
Recenti progressi in medicina. 88(6)
Sumatriptan (SU), a specific 5-HT1D receptor agonist, was recently shown to be able to increase growth hormone (GH) levels in normals, but not in acromegalics, while no effect was seen on prolactine (PRL). SU is also able to produce an increase in GH
Autor:
P. Filippa, G. P. Gorrini, C. M. Cuttica, Massimo Giusti, Giuseppe Delitala, L. Castoldi, Giuseppe Fanciulli, F. Peluffo
Publikováno v:
Aging (Milan, Italy). 9(3)
In aging, both changes in body composition and a decrease in GH secretion are observed. While recombinant human GH (rhGH) therapy was shown to be effective in GH-deficient adults, its effects on normal aging are controversial. This study addressed th
Publikováno v:
Minerva endocrinologica. 20(2)
Serotoninergic receptors are involved in the regulation of PRL and GH secretion. We studied the effects of sumatriptan, a new 5-HT1D receptor agonist, on PRL and GH secretion in active acromegaly.After their informed consent, all subjects were submit
Publikováno v:
Recenti progressi in medicina. 86(5)
This study was undertaken to evaluate effectiveness and tolerability of octreotide administered in active acromegaly by pulsatile means and compare these data with intermittent three-times-a-day therapy. We studied 13 acromegalics with active disease
Publikováno v:
Recenti progressi in medicina. 85(1)
Octreotide, as well as endogenous somatostatin, inhibits GH and TSH secretion. The drug is employed in the medical therapy of acromegaly. We studied the effects of a long-term (1-120 months; median 12 months) therapy with octreotide (300 micrograms/d